Gravar-mail: IMPS-17 BRANCHED-MULTIPEPTIDE IMMUNOTHERAPY FOR GLIOBLASTOMA USING HLA-A*0201-RESTRICTED CYTOTOXIC T-LYMPHOCYTE EPITOPE FROM BIRC5, CD99 AND ERBB2